Nilotinib in Combination with Sunitinib Renders MCL-1 for Degradation and Activates Autophagy That Overcomes Sunitinib Resistance in Renal Cell Carcinoma.
CELLULAR ONCOLOGY（2024）
关键词
Sunitinib,Nilotinib,MCL-1,Autophagy,Renal cell carcinoma,Combination therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要